Wockhardt gets USFDA tentative nod for generic rhinitis drug

Published October 20, 2010

Wockhardt gets USFDA tentative nod for generic rhinitis drug
Pharmaceutical and biotechnology firm Wockhardt today said it has received tentative approval from the US Food & Drug Administration to sell generic version of Sanofi Aventis’ Allegra-D, used for treating allergic rhinitis.
Read more on Hindustan Times

FDA wants heart test before approving Amylin’s diabetes drug
Federal regulators put up another barrier to the approval of Bydureon, Amylin’s experimental weekly injection treatment for diabetes.
Read more on San Diego Union-Tribune

HK court postpones Singson drug case
HONG KONG—A Hong Kong court Tuesday adjourned a drug trafficking case against a Philippine lawmaker and music promoter, saying medical records “needed clarification.”
Read more on Philippine Daily Inquirer